A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa

Author(s):
Huttner, A.; Combescure, C.; Grillet, S.; Haks, M.C.; Quinten, E.; Modoux, C.; Agnandji, S.T.; Brosnahan, J.; Dayer, J.A.; Harandi, A.M.; Kaiser, L.; Medaglini, D.; Monath, T.; Roux-Lombard, P.; Kremsner, P.G.; Ottenhoff, T.H.M. (0000-0003-3706-3403); Siegrist, C.A.; VEBCON VSV EBOVAC Consortia
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-04-12
Language
English
Is part of
Science Translational Medicine (2017), No. 385
hdl
1887/114399
doi
10.1126/scitranslmed.aaj1701